Established in 1979 as a research collaboration between Thailand's Mahidol University and the UK's University of Oxford and Wellcome, the Mahidol Oxford Tropical Medicine Research Unit (MORU) and its Departments, laboratories and Operations & Admin are headquartered in Bangkok, Thailand within Mahidol's Faculty of Tropical Medicine.
Our discipline-specific departments and laboratories in Bangkok and elsewhere work closely with all of our MORU Units and study sites, as well as with the national malaria control programmes and ministries of health in countries across SE Asia and the tropics. This enables us to explore heterogeneity in the causes of infectious diseases and allows us to conduct adequately powered multicentre clinical trials, ensuring the generalizability of results.
This broad interconnected network is coordinated by our Science and Strategy Committee, which meets monthly. We also work together through cross programme disease and discipline working groups (for e.g. in malaria, rickettsial diseases, melioidosis, lab microbiology, mathematical and economic modelling and epidemiology).
Through this process we develop our joint research themes and ensure that our research efforts are efficient, synergistic and directed towards the greatest possible impact on health.
Blood transcriptomics to characterize key biological pathways and identify biomarkers for predicting mortality in melioidosis.
Yimthin T. et al, (2021), Emerging microbes & infections, 10, 8 - 18
Triple artemisinin-based combination therapies for malaria: proceed with caution - Authors' reply.
van der Pluijm RW. et al, (2021), Lancet (London, England), 396, 1976 - 1977
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Abani O. et al, (2021), The Lancet, 397, 1637 - 1645